KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Other financing activities (2017 - 2025)

Elanco Animal Health (ELAN) has disclosed Other financing activities for 9 consecutive years, with -$17.0 million as the latest value for Q4 2025.

  • Quarterly Other financing activities fell 383.33% to -$17.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.0 million through Dec 2025, up 88.24% year-over-year, with the annual reading at -$2.0 million for FY2025, 88.24% up from the prior year.
  • Other financing activities hit -$17.0 million in Q4 2025 for Elanco Animal Health, down from $35.0 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $35.0 million in Q3 2025 to a low of -$20.0 million in Q1 2025.
  • Historically, Other financing activities has averaged -$5.5 million across 5 years, with a median of -$7.5 million in 2023.
  • Biggest five-year swings in Other financing activities: plummeted 1300.0% in 2021 and later soared 537.5% in 2025.
  • Year by year, Other financing activities stood at -$14.0 million in 2021, then skyrocketed by 107.14% to $1.0 million in 2022, then crashed by 200.0% to -$1.0 million in 2023, then skyrocketed by 700.0% to $6.0 million in 2024, then tumbled by 383.33% to -$17.0 million in 2025.
  • Business Quant data shows Other financing activities for ELAN at -$17.0 million in Q4 2025, $35.0 million in Q3 2025, and -$20.0 million in Q1 2025.